February 14th 2025
The company’s Mourenx plant in Southwest France aims to become an API network hub, with first supplies expected by next year.
February 12th 2025
The facilities are expected to offer pharma shipment support by addressing time and temperature-specific requirements.
February 4th 2025
A report offers a comprehensive benchmarking and assessment of pharmaceutical manufacturer engagement with specialty pharmacies.
January 29th 2025
The 7,000 square-foot GMP facility will provide formulation development support, along with analytical testing services.
January 14th 2025
The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
REGENXBIO Opens Gene Therapy Manufacturing Center
GMP facility allows for an increase in AAV vector production
The Impact of War on Drug Supply Chain
A conversation with EY life sciences leaders Jim Welch and Jay Welsh
Dealing with Dangerous Goods
The packaging and shipping of dangerous goods (DG) adds further challenges to the distribution pressures brought about by the pandemic
Navigating Uneven Terrain in Labeling
The crucial link of labeling and packaging in the pharma supply chain has its glory, but is not without its set of obstacles amid current market and global challenges
Coriolis Pharma to Expand German HQ
Project is expected to grow CRDO’s capacity by over 150,000 square feet
Via Partnership, Evonik and US Government Invest $220 Million toward Lipid Production Plant
Facility, with expected completion of 2025, will specialize in mRNA-based therapies
Piramal Pharma Advances Oral Solid Dose Capabilities
As a result of new production area, India site’s total production capacity rises from 3 to 4.5 billion doses
Catalent Commits $175 Million to Upgrading Kentucky Facility
Investment will grow manufacturing capabilities at Winchester site
LOTTE to Purchase BMS Manufacturing Facility in New York
East Syracuse site will serve as a hub for company’s US biologics CDMO business
Cytiva Opening a New CGT Switzerland Facility
Among functions, 80,000 square-foot space will house a 'Center of Excellence'
PCI Pharma Services to Invest $100 Million in New Hampshire Facility
Location will feature aseptic fill-finish technology
Matica Bio Opens New Texas CGT Facility
Among efforts, part of center’s focus revolves providing tools for product commercialization
BeiGene Officially Breaks Ground on New Jersey Manufacturing and Clinical R&D Center
Facility will feature biologic manufacturing, along with late-stage research and clinical development of cancer medicines
Fujifilm Begins BioProcess Innovation Center Expansion Project
Expected to be ready by mid-2024
Catalent Obtains Erytech Pharma Manufacturing Facility
Deal for New Jersey cell therapy site totals $44.5 million
Scorpion Biological Services to Construct Kansas Biomanufacturing Facility
Commercial-scale center will cost $650 million, featuring 144,000 liters of biomanufacturing capacity
Asahi Kasei Medical Acquires Bionova Scientific
Deal adds biopharma services to its capabilities
Catalent to Invest $350M in Bloomington, IN Site
Will address biologics drug substance and drug product manufacturing services
Sanofi Invests in Singapore Vaccine Production Site
Factory will reportedly provide capability of manufacturing 3-4 vaccines simultaneously
Akron Bio Unveils New Advanced Gene Therapy and Vaccine Production Facility
Biotech company hopes to tackle challenges surrounding therapeutics
Asymchem Builds Two New Production Sites
Expansion expected to double batch capacity
Biovectra Begins Construction of mRNA Vaccine Biomanufacturing Center
Includes a 36,000-square-foot addition to Charlottetown location
Yourway Continues HQ Expansion Project
Includes 100,000 square feet of controlled ambient storage
VectorBuilder Grows R&D Services, Unveils $500 Million China Construction Project
Campus will feature a CDMO, over 1,000,000 square feet of floor space
Going with the Phlow
Company strives to provide essential medicines that are in low supply
Catalent Acquires UK Biologics Facility
CDMO will invest up to $160 million toward manufacturing of therapies and vaccines, including mRNA
Ten23 Health Further Develops Sterile Drug Product Manufacturing at Visp, Switzerland Location
Features growth of cold storage, visual inspections capacity
Symbiosis Successfully Completes UK Research and Innovation Project
Collective project expected to enhance the manufacturing supply chain for ATMPs within the UK
KeyPlants Dispatches Vaccine Manufacturing Facility to Senegal
Will have capability of producing 300 million COVID-19 vaccines for Africa annually
Setting Science Free
How CDMOs will lead the way toward true cloud lab enablement